Urban Training for COPD Patients
- Conditions
- Chronic Obstructive Pulmonary Disease (COPD)
- Interventions
- Behavioral: Urban training
- Registration Number
- NCT01897298
- Lead Sponsor
- Judith Garcia-Aymerich
- Brief Summary
This project plans on a training intervention by using public spaces and urban walkable trails, adapted to each patient needs and capabilities. Primary objective is to assess 12 months effectiveness of the intervention with respect to: (primary outcome): physical activity level, and (secondary outcomes): COPD admissions, exercise capacity, body composition, quality of life, and mental health.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 412
- age > 45 years
- COPD diagnosed by pulmonary function tests during clinical stability, with a ratio of forced expiratory volume in one second (FEV1) to forced vital capacity (FVC) ≤ 0.70
- clinical stability, defined as at least 4 weeks without antibiotics or oral corticosteroids.
- living >6 months/year outside of the included municipalities,
- living to a distance higher than 500 meters to any of the urban trails used for the study,
- mental disability according to the Mini Mental State Examination in its validated Spanish version
- comorbidity that could interfere with study tests (e.g., lower limb amputation)
- severe psychiatric disease or severe comorbidity limiting survival at one year, according to medical history.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description Urban training Intervention Urban training Patients will be advised to walk in the defined urban trails.
- Primary Outcome Measures
Name Time Method Change in physical activity Baseline and 12 months follow-up Change in physical activity between baseline and 12 months follow-up, as defined by average steps per day measured with an activity monitor
- Secondary Outcome Measures
Name Time Method COPD admissions to emergency-room or hospital 12 months follow-up Change in exercise capacity, as measured with 6-min walking distance Baseline and 12 months Change in exercise capacity between baseline and 12 months, as measured with 6-min walking distance
Change in body weight and composition Baseline and 12 month Change in body weight and composition between baseline and 12m follow-up, as measured with bioimpedance
Change in quality of life Baseline and 12-m Change in quality of life between baseline and 12-m follow-up, as measured with CAT and CCQ
Change in anxiety and depression symptoms Baseline and 12 months Change in anxiety and depression symptoms between baseline and 12 months follw-up, as measured with the HAD scale
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
Trial Locations
- Locations (5)
CAP Maria Bernades
🇪🇸Viladecans, Barcelona, Spain
Hospital Germans Trias i Pujol
🇪🇸Badalona, Barcelona, Spain
CAP Maresme
🇪🇸Mataró, Barcelona, Spain
Hospital Clinic
🇪🇸Barcelona, Spain
Hospital del Mar
🇪🇸Barcelona, Spain